Related Experiment Video
Updated: May 13, 2026

A Unified Methodological Framework for Vestibular Schwannoma Research
Published on: June 20, 2017
Three risk factors for WHO grade II and III meningiomas: A study of 1737 cases from a single center
Peizhi Zhou1, Weichao Ma, Senlin Yin
1Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, Sichuan Province, China.
Background:
Meningiomas account for 35.5% of central nervous system (CNS) tumors, of which 21-37.8% are atypical or anaplastic/malignant. High-grade meningiomas have higher rates of recurrence and worse outcome than grade I/II meningiomas. Thus, it is of importance to assess the tumor biology before treatment initiation.
Materials And Methods:
This study reviewed 1737 patients with histologically confirmed meningioma at a single institution. Meningiomas were classified according to World Health Organization (WHO) 2007 grading and the location of the tumor was confirmed from the operation records and preoperative imaging. Univariate and multivariate logistic regression were used to analyze the potential risk factors for high-grade pathology.
Results:
Young men and pediatric patients were less likely to have meningioma, but they had high-grade meningioma. Tumors originated from non-skull base and lateral intracranial are more likely to be grade II/III meningioma.
Conclusions:
Lateral and non-skull base location, male sex, and the younger patients increase the risk for grade II and III pathology. These factors should be considered while deciding treatment choice, surgical resection, and prognosis as well.
Insights
Younger males and pediatric patients are more prone to high-grade meningiomas. Tumors located laterally or away from the skull base also indicate a higher risk of aggressive meningioma (WHO grade II/III).
Area of Science:
- Neurosurgery
- Oncology
- Pathology
Background:
- Meningiomas represent a significant portion of central nervous system (CNS) tumors.
- A substantial percentage (21-37.8%) are high-grade (atypical or anaplastic/malignant), associated with poorer outcomes.
- Early assessment of tumor biology is crucial for effective management.
Purpose of the Study:
- To identify risk factors associated with high-grade meningioma (WHO grade II/III).
- To inform treatment decisions, surgical planning, and prognostic assessments.
Main Methods:
- Retrospective review of 1737 patients with histologically confirmed meningioma.
- Classification of meningiomas based on WHO 2007 grading system.
- Analysis of tumor location using operation records and preoperative imaging.
- Logistic regression models to determine risk factors for high-grade pathology.
Main Results:
- Younger male patients and pediatric cases showed a higher likelihood of high-grade meningioma.
- Meningiomas originating from non-skull base and lateral intracranial locations were more frequently high-grade (grade II/III).
Conclusions:
- Lateral and non-skull base tumor locations are significant risk factors for WHO grade II/III meningioma.
- Male sex and younger patient age are also associated with an increased risk of high-grade pathology.
- These identified factors are critical for guiding treatment strategies and prognosis in meningioma patients.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Bacterial Meningitis I: Introduction
Increased Intracranial Pressure ll: Pathophysiology
